FIELD: biotechnology.
SUBSTANCE: invention relates to use of methylcobalamin in promoting nerve regeneration and can be used in medicine for treating diseases of the nervous system. Presented is a method involving administering an agent consisting of methylcobalamin as an active ingredient by continuous intravenous drop infusion.
EFFECT: invention provides effective treatment of such nervous system diseases as cerebral infarction or spinal cord injury.
5 cl, 23 dwg, 20 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
| METHOD FOR MODULATING AND METHOD FOR STIMULATING GROWTH CENTRAL NERVOUS SYSTEM NEURON AXONS AND FOR TREATING FOR INSULT AND PACKED PHARMACEUTICAL PREPARATION | 1998 |
|
RU2212241C2 |
| CELL-BASED THERAPY OF ISCHEMIC TISSUE | 2009 |
|
RU2535966C2 |
| NEW TREATMENT OF MULTIPLE SCLEROSIS (MS) | 2011 |
|
RU2595861C2 |
| COMPOSITION FOR PREVENTION AND TREATMENT OF SPINAL CORD INJURY | 2019 |
|
RU2750201C1 |
| TRANSPLANTATION OF NERVE CELLS FOR TREATMENT OF NEURODEGENERATIVE STATES | 2005 |
|
RU2434636C2 |
| NEW APPLICATION | 2004 |
|
RU2416426C2 |
| SPECIFIC HEXOKINASE-2 INHIBITORS FOR USE IN ACUTE CENTRAL NERVOUS SYSTEM DAMAGE | 2018 |
|
RU2736499C1 |
| ACTIVITY MODULATOR | 2018 |
|
RU2773957C2 |
| COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES | 2005 |
|
RU2387453C2 |
